Cargando…
Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model
BACKGROUND: Bone marrow-derived stromal cells (BMSCs) are important for development, tissue cell replenishment, and wound healing in physiological and pathological conditions. BMSCs were found to preferably reach sites undergoing the process of cell proliferation, such as wound and tumor, suggesting...
Autores principales: | Hu, M, Yang, J-L, Teng, H, Jia, Y-Q, Wang, R, Zhang, X-W, Wu, Y, Luo, Y, Chen, X-C, Zhang, R, Tian, L, Zhao, X, Wei, Y-Q |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580769/ https://www.ncbi.nlm.nih.gov/pubmed/18947384 http://dx.doi.org/10.1186/1471-2407-8-306 |
Ejemplares similares
-
sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo
por: Altiok, Eda I., et al.
Publicado: (2016) -
Mechanical stimulation orchestrates the osteogenic differentiation of human bone marrow stromal cells by regulating HDAC1
por: Wang, J, et al.
Publicado: (2016) -
Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1
por: Eslani, Medi, et al.
Publicado: (2017) -
RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018) -
Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice
por: Zhu, H, et al.
Publicado: (2011)